Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimers disease
Our clinical team creates treatment plans designed specifically for you and your metabolic profile
Help us provide the best care by informing us about all medications you take, including the specific GLP-1 drug, dose, and when you started it
While the results were statistically significant, we'd love to see these findings replicated in larger groups
Z kolei osoby, ktre duo wicz, uprawiaj sport wyczynowo lub redukuj tkank tuszczow powinny przyjmowa okoo 300-1000 mg dziennie L-karnityny
Transdermal patches like GLPatch bypass that entire pathway by absorbing through the skin